Search Results for: PRKACA

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
CALD1 caldesmon 1
  • Smooth Muscle Contraction
CAMKK2 calcium/calmodulin dependent protein kinase kinase 2
  • CaMK IV-mediated phosphorylation of CREB
  • CaMK IV-mediated phosphorylation of CREB
  • CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
  • CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
  • Activation of RAC1 downstream of NMDARs
  • Activation of RAC1 downstream of NMDARs
  • Activation of AMPK downstream of NMDARs
  • Fostamatinib
CCDC88A coiled-coil domain containing 88A
CCND1 cyclin D1
  • SCF(Skp2)-mediated degradation of p27/p21
  • Pre-NOTCH Transcription and Translation
  • RMTs methylate histone arginines
  • Interleukin-4 and Interleukin-13 signaling
  • Cyclin D associated events in G1
  • Ubiquitin-dependent degradation of Cyclin D
  • Ubiquitin-dependent degradation of Cyclin D
  • PTK6 Regulates Cell Cycle
  • Transcriptional Regulation by VENTX
  • Transcriptional regulation by RUNX2
  • Regulation of RUNX1 Expression and Activity
  • RUNX3 regulates WNT signaling
  • RUNX3 regulates p14-ARF
  • Estrogen-dependent gene expression
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)
  • Acetylsalicylic acid
  • Arsenic trioxide
  • Encorafenib
  • Bryostatin 1
  • Hairy-cell leukemia
  • von Hippel-Lindau syndrome
  • Esophageal cancer
  • Oral cancer
  • Multiple myeloma
  • Laryngeal cancer
  • Breast cancer
CDK16 cyclin dependent kinase 16
  • (2Z,3E)-2,3'-biindole-2',3(1H,1'H)-dione 3-{O-[(3R)-3,4-dihydroxybutyl]oxime}
  • Fostamatinib
CDKN1A cyclin dependent kinase inhibitor 1A
  • SCF(Skp2)-mediated degradation of p27/p21
  • AKT phosphorylates targets in the cytosol
  • Senescence-Associated Secretory Phenotype (SASP)
  • DNA Damage/Telomere Stress Induced Senescence
  • Constitutive Signaling by AKT1 E17K in Cancer
  • Interleukin-4 and Interleukin-13 signaling
  • TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
  • Cyclin E associated events during G1/S transition
  • Cyclin D associated events in G1
  • p53-Dependent G1 DNA Damage Response
  • Cyclin A:Cdk2-associated events at S phase entry
  • Transcriptional activation of cell cycle inhibitor p21
  • The role of GTSE1 in G2/M progression after G2 checkpoint
  • TFAP2 (AP-2) family regulates transcription of cell cycle factors
  • Transcriptional regulation by RUNX2
  • RUNX3 regulates CDKN1A transcription
  • Transcriptional regulation of granulopoiesis
  • FOXO-mediated transcription of cell cycle genes
  • Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)
  • STAT5 activation downstream of FLT3 ITD mutants
  • Signaling by FLT3 fusion proteins
  • Arsenic trioxide
  • Cervical cancer
CETN1 centrin 1
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • Aggrephagy
  • Aggrephagy
CFTR CF transmembrane conductance regulator
  • ABC-family proteins mediated transport
  • RHO GTPases regulate CFTR trafficking
  • Defective CFTR causes cystic fibrosis
  • Ub-specific processing proteases
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • Aggrephagy
  • Aggrephagy
  • ATP
  • Bumetanide
  • Glyburide
  • Ibuprofen
  • Colforsin
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • Dexfosfoserine
  • Crofelemer
  • Lonidamine
  • Ivacaftor
  • Dexibuprofen
  • Lumacaftor
  • Tezacaftor
  • Elexacaftor
  • Cystic fibrosis (CF)
  • Hereditary pancreatitis; Hereditary chronic pancreatitis
  • Congenital bilateral absence of vas deferens
CIITA class II major histocompatibility complex transactivator
  • Interferon gamma signaling
  • Bare lymphocyte syndrome (BLS) type2
  • Combined immunodeficiencies (CIDs), including the following nine diseases: X-linked hyper IgM syndrome; CD40 deficiency hyper IgM syndrome; Purine nucleoside phosphorylase (PNP) deficiency; Omenn syndrome; MHC deficiency (HLA-class I); MHC deficiency (HLA-class II); Zap-70 deficiency; p56 Lck deficiency; CD8 deficiency
CLDN3 claudin 3
  • Tight junction interactions
CLTC clathrin heavy chain
  • Entry of Influenza Virion into Host Cell via Endocytosis
  • Retrograde neurotrophin signalling
  • Retrograde neurotrophin signalling
  • Gap junction degradation
  • Formation of annular gap junctions
  • MHC class II antigen presentation
  • EPH-ephrin mediated repulsion of cells
  • Lysosome Vesicle Biogenesis
  • Recycling pathway of L1
  • Recycling pathway of L1
  • WNT5A-dependent internalization of FZD4
  • WNT5A-dependent internalization of FZD2, FZD5 and ROR2
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • VLDLR internalisation and degradation
  • LDL clearance
CREB1 cAMP responsive element binding protein 1
  • PKA-mediated phosphorylation of CREB
  • CaMK IV-mediated phosphorylation of CREB
  • AKT phosphorylates targets in the nucleus
  • CREB phosphorylation
  • Transcriptional activation of mitochondrial biogenesis
  • Transcriptional activation of mitochondrial biogenesis
  • NOTCH2 intracellular domain regulates transcription
  • NCAM signaling for neurite out-growth
  • Circadian Clock
  • Circadian Clock
  • CREB1 phosphorylation through the activation of Adenylate Cyclase
  • CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
  • CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling
  • Constitutive Signaling by AKT1 E17K in Cancer
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Regulation of MECP2 expression and activity
  • MECP2 regulates neuronal receptors and channels
  • MECP2 regulates transcription of neuronal ligands
  • MECP2 regulates transcription factors
  • NGF-stimulated transcription
  • NGF-stimulated transcription
  • HCMV Early Events
  • Transcriptional regulation of granulopoiesis
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • ADORA2B mediated anti-inflammatory cytokines production
  • ADORA2B mediated anti-inflammatory cytokines production
  • FCGR3A-mediated IL10 synthesis
  • FCGR3A-mediated IL10 synthesis
  • Adenosine phosphate
  • Naloxone
CREM cAMP responsive element modulator
CRK CRK proto-oncogene, adaptor protein
  • ARMS-mediated activation
  • ARMS-mediated activation
  • Downstream signal transduction
  • Regulation of actin dynamics for phagocytic cup formation
  • p130Cas linkage to MAPK signaling for integrins
  • VEGFA-VEGFR2 Pathway
  • PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
  • MET activates RAP1 and RAC1
  • MET receptor recycling
  • Regulation of signaling by CBL
  • FCGR3A-mediated phagocytosis
CSK C-terminal Src kinase
  • GAB1 signalosome
  • Phosphorylation of CD3 and TCR zeta chains
  • Integrin signaling
  • PD-1 signaling
  • MAP2K and MAPK activation
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by high-kinase activity BRAF mutants
  • Signaling by BRAF and RAF fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Signaling downstream of RAS mutants
  • Signaling by RAF1 mutants
  • Negative regulation of FLT3
  • Dasatinib
  • Staurosporine
  • TG-100801
  • Fostamatinib
CUL5 cullin 5
  • Vif-mediated degradation of APOBEC3G
  • Downregulation of ERBB2 signaling
  • Neddylation
  • Antigen processing: Ubiquitination & Proteasome degradation
CYP3A4 cytochrome P450 family 3 subfamily A member 4
  • Xenobiotics
  • Aflatoxin activation and detoxification
  • Biosynthesis of maresin-like SPMs
  • Glutathione
  • Isoniazid
  • Pradefovir mesylate
  • Casopitant
  • Diacerein
DMTN dematin actin binding protein
  • Miscellaneous transport and binding events
DNAJC5 DnaJ heat shock protein family (Hsp40) member C5
  • Neutrophil degranulation
  • GABA synthesis, release, reuptake and degradation
DOCK1 dedicator of cytokinesis 1
  • Regulation of actin dynamics for phagocytic cup formation
  • DCC mediated attractive signaling
  • DCC mediated attractive signaling
  • VEGFA-VEGFR2 Pathway
  • PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
  • FCGR3A-mediated phagocytosis
  • Factors involved in megakaryocyte development and platelet production

Page 3 out of 11 pages